TABLE 1.
Clinicopathological characteristics of cervical cancer patients (N = 246).
| Clinicopathological characteristics | Total cases | Concordant cases |
| Age, years, n (%) | ||
| ≤45 | 29 (11.8) | 25 (86.2) |
| 45–65 | 165 (67.1) | 134 (81.2) |
| ≥65 | 52 (21.1) | 20 (38.5) |
| Median age (range) | 53(35−78) | – |
| Registered residence, n (%) | ||
| Urban registration | 81 (33.8) | 78 (96.3) |
| Rural registration | 165 (66.2) | 101 (61.2) |
| ECOGa performance status, n (%) | ||
| 0–1 points | 186 (75.6) | 145 (77.9) |
| 2 points | 47 (19.1) | 31 (66.1) |
| ≥3 points | 13 (5.3) | 3 (23.1) |
| FIGO stage, n (%) | ||
| I | 29 (11.8) | 12 (41.4) |
| II | 101 (41.1) | 87 (86.1) |
| III | 90 (36.6) | 78 (86.7) |
| IV | 26 (10.5) | 2 (7.96) |
| Lymphatic metastasis, n (%) | ||
| Positive | 114 (46.3) | 82 (71.9) |
| Negative | 132 (53.7) | 97 (73.5) |
| Distant metastasis, n (%) | ||
| Positive | 19 (7.7) | 10 (52.6) |
| Negative | 227 (92.3) | 169 (74.5) |
| Pathological types, n (%) | ||
| Squamous cell carcinoma | 219 (89.0) | 159 (72.6) |
| Adenocarcinoma | 16 (6.5) | 125 (75) |
| Adenosscale squamous cell carcinoma | 10 (4.1) | 7 (70) |
| Small cell carcinoma | 1 (0.4) | 1 (100) |
| Differentiation degrees, n (%) | ||
| High differentiation | 48 (19.5) | 35 (72.9) |
| Middle differentiation | 90 (36.6) | 64 (71.1) |
| Poorly differentiation | 108 (43.9) | 80 (74.1) |
aEastern Cooperative Oncology Group, ECOG.